|
[多种化疗方案]
HAIC研究的潜在障碍:多种化疗方案
日期:2021-12-28 11:54:22
点击:99
A standard chemotherapy regimen for HAIC has yet to be established, increasing the challenge of interpreting trial results. HAIC的标准化疗方案尚未建立,这增加了解释试验结果的挑战。 Cisplatin and 5-FU were the most commonly used chemotherap...
[异质性患者数据]
HAIC研究潜在障碍:数据的异质性
日期:2021-12-27 15:27:25
点击:99
Studies on HAIC have included populations with various degrees of intrahepatic tumor burden, including the possible presence of PVT/EHS. 对HAIC的研究包括了不同程度肝内肿瘤负荷的人群,包括可能存在PVT/EHS。 Studies on patients with PVT who r...
[+ 免疫治疗]
HAIC 联合免疫治疗
日期:2021-12-27 08:50:24
点击:99
Immune checkpoint inhibitorbased combinations have changed the treatment paradigm for advanced HCC [59,60] and are likely to remain the cornerstone of systemic treatment in the next few years. 基于免疫检查点抑制剂的联合治疗已经改变了晚期HC...
[+ 放疗]
HAIC 联合放疗
日期:2021-12-25 11:25:23
点击:99
HAIC combined with radiation therapy (RT) has also been extensively investigated, particularly in subgroups of patients with PVT. HAIC联合放疗(RT)也已被广泛研究,特别是在PVT患者的亚组中。 Han et al. [ 51 ] conducted a small-scale single-ar...
[+ 多激酶抑制剂]
HAIC联合多激酶抑制剂
日期:2021-12-25 07:06:16
点击:99
HAIC has been combined with sorafenib to leverage the synergistic effects of the combination. HAIC已与索拉非尼联合使用,以利用该联合使用的协同效应。 A randomized Phase 2 trial was conducted to compare HAIC plus sorafenib with sorafenib alo...
[+ 干扰素α]
HAIC联合皮下干扰素α
日期:2021-12-24 23:56:05
点击:99
Subcutaneous or intramuscular interferon-alpha (IFN-) has been used in combination with intravenous chemotherapy for advanced HCC to enhance antitumor activity [55]. 皮下或肌内干扰素(IFN-)已与静脉化疗联合用于晚期HCC,以增强抗肿瘤活性[ 55 ]...
[定义]
非肝硬化门静脉高压定义
日期:2021-12-13 13:32:09
点击:99
肝( 窦) 前型非肝硬化门静脉高压症( non - cirrhotic portal hypertension,NCPH) 是一组预后可能较好、病因少见或复杂的门静脉系统或全身性疾病,肝脏功能基本正常、肝 静 脉 压 力 梯 度 ( hepatic venous pressure gradient,HVPG) 正常或轻度增加为特征...
[难治性肝性胸腹水]
TIPS适应症:肝性胸水
日期:2021-12-13 12:14:59
点击:99
肝性胸水(Hepatic hydrothorax,HH) HH is the accumulation of a significant amount of transudative fluid, usually over 500 mL, in the pleural cavity of patients with decompensated liver cirrhosis without coexisting primary cardiopulmonary...
[难治性腹水]
TIPS适应症:腹水
日期:2021-12-10 17:14:38
点击:99
Ascites is the most common complication of PH in cirrhosis, with approximately 60% of compensated cirrhosis patients developing the condition within ten years of diagnosis[74]. 腹水是肝硬化中PH最常见的并发症,约60%的代偿性肝硬化患者在诊断...
[肝肾综合征]
TIPS适应症:肝肾综合征
日期:2021-12-10 17:13:18
点击:99
HRS is usually manifested in the advanced stage of cirrhosis with PH. HRS(Hepatorenal Syndrome)发生在门静脉高压肝硬化晚期。(严重肝病晚期可能出现的一种并发症) International Club of Ascites has defined HRS as an increase in serum creatinin...
经导管动脉化疗性栓塞(Transcatheter arterial chemotherapy,TACE)是一种治疗肝脏...
适应症 当患者无法 正常 通过经口途径满足饮食热量摄入时:95%的病例 头颈部肿瘤、围...
男,69岁 - 代谢功能障碍肝硬化合并酒精性肝病(MetALD) - II型糖尿病,高血压 - Chi...
局部治疗联合免疫治疗原理...
单纯肝动脉栓塞的背景 Bland embolisation: Background 肝癌单纯栓塞(Bland emboliza...
肝细胞癌(HCC)是癌症死亡的重要原因,被认为是世界上第三大致命疾...